Paragon Private Wealth Management LLC Sells 191 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Paragon Private Wealth Management LLC lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.6% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,311 shares of the exchange traded fund’s stock after selling 191 shares during the period. Paragon Private Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $208,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of the stock. Hartline Investment Corp grew its holdings in SPDR S&P Biotech ETF by 2.0% during the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock valued at $544,000 after purchasing an additional 106 shares during the period. Addison Advisors LLC grew its holdings in SPDR S&P Biotech ETF by 27.4% during the fourth quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock valued at $48,000 after purchasing an additional 115 shares during the period. Signature Estate & Investment Advisors LLC lifted its position in shares of SPDR S&P Biotech ETF by 5.7% in the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock valued at $231,000 after acquiring an additional 125 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of SPDR S&P Biotech ETF by 0.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock valued at $2,373,000 after acquiring an additional 148 shares in the last quarter. Finally, Invst LLC lifted its position in shares of SPDR S&P Biotech ETF by 6.0% in the third quarter. Invst LLC now owns 2,807 shares of the exchange traded fund’s stock valued at $277,000 after acquiring an additional 160 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 1.2 %

Shares of SPDR S&P Biotech ETF stock opened at $86.24 on Tuesday. The stock’s 50-day simple moving average is $90.41 and its 200-day simple moving average is $95.19. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The company has a market capitalization of $5.69 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.